FDA panel backs Pfizer drug for kidney cancer
A panel of advisers to the Food and Drug Administration voted Wednesday that the benefits of a Pfizer kidney cancer drug outweigh its risks, according to a company spokeswoman.
View full post on Yahoo! Health News
backs, Cancer, drug, kidney, Panel, Pfizer